Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Nihei

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy]Satoru Nihei, Junya Sato, Masahiro Kashiwaba, et al.
Japanese Journal of Clinical Oncology|March 9, 2016
Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapyJunya Sato, Masahiro Kashiwaba, Hideaki Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[Treatment algorithm for oxaliplatin-induced peripheral neuropathy]Satoru Nihei, Junya Sato, Toshimoto Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2024
[Patient Questionnaire Survey of"As-Needed"Medications to Relieve Side Effects and Anxiety for Breast Cancer Chemotherapy]Tatsuki Ikeda, Satoru Nihei, Kazuki Saito, et al.
Journal of Pharmaceutical Health Care and Sciences|November 29, 2016
The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathyJunya Sato, Megumi Mori, Satoru Nihei, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2025
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational studySatoru Nihei, Kazuki Saito, Tatsuki Ikeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 20, 2016
[The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy]Yasuhiro Mizukami, Junya Sato, Satoru Nihei, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2023
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancerSatoru Nihei, Tatsuki Ikeda, Tomohiko Aoki, et al.
Journal of Pharmaceutical Health Care and Sciences|March 8, 2016
Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancerJunya Sato, Naoto Morikawa, Hiroo Nitanai, et al.
Biological & Pharmaceutical Bulletin|November 2, 2018
Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes MellitusTakeshi Chiba, Satoru Nihei, Hideaki Komatsu, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy]Satoru Nihei, Junya Sato, Masahiro Kashiwaba, et al.
Japanese Journal of Clinical Oncology|March 9, 2016
Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapyJunya Sato, Masahiro Kashiwaba, Hideaki Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[Treatment algorithm for oxaliplatin-induced peripheral neuropathy]Satoru Nihei, Junya Sato, Toshimoto Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2024
[Patient Questionnaire Survey of"As-Needed"Medications to Relieve Side Effects and Anxiety for Breast Cancer Chemotherapy]Tatsuki Ikeda, Satoru Nihei, Kazuki Saito, et al.
Journal of Pharmaceutical Health Care and Sciences|November 29, 2016
The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathyJunya Sato, Megumi Mori, Satoru Nihei, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2025
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational studySatoru Nihei, Kazuki Saito, Tatsuki Ikeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 20, 2016
[The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy]Yasuhiro Mizukami, Junya Sato, Satoru Nihei, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2023
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancerSatoru Nihei, Tatsuki Ikeda, Tomohiko Aoki, et al.
Journal of Pharmaceutical Health Care and Sciences|March 8, 2016
Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancerJunya Sato, Naoto Morikawa, Hiroo Nitanai, et al.
Biological & Pharmaceutical Bulletin|November 2, 2018
Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes MellitusTakeshi Chiba, Satoru Nihei, Hideaki Komatsu, et al.
Pageof 3